A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(15 sites)

United States

University of Alabama at Birmingham, Birmingham, Alabama

Bleeding and Clotting Disorders Institute, Peoria, Illinois

Riley Hospital for Children Indiana University Health, Indianapolis, Indiana

University of Iowa Hospitals & Clinics PARENT, Iowa City, Iowa

Childrens Hospital of Michigan, Detroit, Michigan

Children's Health Care d/b/a Children's Minnesota, Minneapolis, Minnesota

Rutgers - Robert Wood Johnson Medical School, New Brunswick, New Jersey

New York - Presbyterian/Weill Cornell Medical Center, New York, New York

Medical University of South Carolina (MUSC), Charleston, South Carolina

France

Hemostase Clinique - Institut Cœur-Poumons (4eme étage aile est) Bureau 419, Lille

Hopital Edouard Herriot - CHU Lyon, Lyon

Ireland

Children's Health Ireland, Dublin

Italy

Azienda Ospedaliera Pediatrica Santobono Pausillipon, Naples

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin (Torino)

Japan

Nara Medical University Hospital, Kashihara